Bank of America’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bank of America’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,464	Closed	-$51.4K	–	8514
2024 Q1	$51.4K	Sell	10,464 -22,010	-68%	-$104K	﹤0.01%	6507
2023 Q4	$119K	Buy	32,474 +14,808	+84%	+$40.6K	﹤0.01%	6308
2023 Q3	$39.2K	Buy	17,666 +11,946	+209%	+$33.3K	﹤0.01%	6570
2023 Q2	$19.4K	Sell	5,720 -9,416	-62%	-$34K	﹤0.01%	6716
2023 Q1	$60.4K	Sell	15,136 -5,004	-25%	-$22K	﹤0.01%	6440
2022 Q4	$110K	Buy	20,140 +13,260	+193%	+$78K	﹤0.01%	6195
2022 Q3	$35K	Sell	6,880 -2,908	-30%	-$14.3K	﹤0.01%	6821
2022 Q2	$37K	Buy	+9,788	New	+$62.5K	﹤0.01%	6972

Bank of America's TGAN Position: Q2 2024 in Review

Bank of America sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 10,464 shares — an estimated $51.4K sold.

Bank of America first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $119K in Q4 2023. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Bank of America reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bank of America sold 10,464 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $51.4K.
Bank of America first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Bank of America's Transphorm, Inc. Common Stock position peaked at $119K in Q4 2023.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.